Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Accelerate to discover
Related topics
Oct 3, 2023
New features across the PMOD toolbox support reproducible and high-throughput analyses. Performance is improved and a...
Drive key insights and discoveries with NEW Live Cell Analysis applications for eSight system
Aug 2, 2023
eSight is now powerful like never before. Learn more about new dedicated application modules for live-cell analysis: 3D...
High speed, compact and fully automated microscope inside your incubator? Lumascope850
Jul 13, 2023
The powerful, new LS850 Microscope is the latest generation of our fully automated three-channel flagship model and...
InAlyzer - The technology chosen by NASA
Jul 10, 2023
MEDIKORS's InAlyzer was finally selected as the equipment to be used for NASA's space environment biological research
FLO i8 - new liquid handler with 8 independently spanning channels
Jun 1, 2023
The FLO i8 Liquid Handler is ideal for optimizing your protocols and bench work, allowing you to focus on the research,...
Precision Launches CellRadHD – The Next Generation High-Dose Benchtop Irradiator
May 31, 2023
New CellRadHD offers the highest dose available in a benchtop unit. Up to 160kV, this irradiator is maximizing...
Cardiomyocyte isolation using Cellenion’s cellenONE instrument
Mar 24, 2023
The cellenONE platform is ideal for the isolation of fragile and heterogeneous cell size populations, such as...
Introducing Cytek Human Leukocyte Kit, the first ever 15-color lyse no-wash assay
Mar 13, 2023
This kit has been designed to enumerate all major leukocyte subsets and it mirrors and expands on those identified in a...
Sep 29, 2015
The xCELLigence RTCA CardioECR System allows for comprehensive evaluation of processes involved in cardiomyocyte excitation-contraction coupling. The included software package is specifically designed to identify and measure adverse compound action on integrated ion channel activity, contractility and longer term viability and thus provides a highly predictive assay system for cardiac risk assessment.
The principle of detection for the xCELLigence RTCA CardioECR System is based on impedance and field potential measurements. The interdigitated gold impedance electrodes are interspersed with two field potential electrodes. These electrodes are specially designed for simultaneous measurement of field potential and contractility within each well of the microtiter plate.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com